Product Center
Ab&B Bio Tech Co., Ltd. JS Invited to Attend the China-Uruguay Trade Cooperation Seminar
- Categories:Company news
- Author:
- Origin:
- Time of issue:2023-11-28
- Views:
(Summary description)During President Lacalle's visit to China, the China-Uruguay Trade Cooperation Seminar, organized by the China Council for the Promotion of International Trade, was held in Beijing on the 21st. Uruguayan President Lacalle attended the forum and delivered a speech. Uruguay's Foreign Minister Omar Paganini and Minister of Agriculture, Livestock, and Fisheries Fernando Mattos also delivered speeches. Representatives from both governments and business communities attended and exchanged views.
Ab&B Bio Tech Co., Ltd. JS Invited to Attend the China-Uruguay Trade Cooperation Seminar
(Summary description)During President Lacalle's visit to China, the China-Uruguay Trade Cooperation Seminar, organized by the China Council for the Promotion of International Trade, was held in Beijing on the 21st. Uruguayan President Lacalle attended the forum and delivered a speech. Uruguay's Foreign Minister Omar Paganini and Minister of Agriculture, Livestock, and Fisheries Fernando Mattos also delivered speeches. Representatives from both governments and business communities attended and exchanged views.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2023-11-28 15:20
- Views:
Ab&B Bio Tech Co., Ltd. JS was invited to participate in this seminar and had in-depth, friendly cooperation and exchanges with government representatives and business professionals in attendance.
During the event, Mr. An Youcai, Chairman of Ab&B Bio Tech Co., Ltd. JS, was invited to meet with Uruguay's Minister of Industry, Energy, and Mining, Ms. Elisa Facio, at the Diaoyutai State Guesthouse. The two sides held in-depth discussions on potential cooperation in their respective fields, laying a solid foundation for future projects.
Relevant information
-
Ab&B Bio-Tech Co., Ltd. collaborates with Walvax Biotechnology Co., Ltd. to seamlessly connect the third-generation subunit influenza vaccine and embark on a new journey of going globalOn March 13, 2026, Ab&B Bio-Tech Co., Ltd. (hereinafter referred to as "Ab&B Bio") and Walvax Biotechnology Co., Ltd. (hereinafter referred to as "Walvax") officially signed a strategic cooperation agreement for the overseas market of influenza virus subunit vaccines in Taizhou. Both parties announced that they will jointly promote the development of the influenza virus subunit vaccine independently developed by Ab&B Bio and set sail to the sea. This is not only a milestone moment for Chinese vaccine companies to cooperate and build a healthy industry ecosystem, but also signifies that China will bring safer and more effective solutions to the global influenza prevention and control field. - Monkeypox mRNA Vaccine Secures FDA Clinical Approval, Trivalent Influenza Virus Subunit Vaccine Wins First Bid in Shanxi 03-04
- Announcement of Pre increase in Performance for 2025 Released 02-26
- Ab&B Bio-Tech Co., Ltd. has been included in the Hang Seng Composite Index, and its recognition in the capital market continues to increase 02-16
- The study on pregnant women receiving quadrivalent influenza virus subunit vaccine has successfully completed key enrollment 02-10
Got a project? Contact us today !
At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.
Contact
E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
